See more : Llorente & Cuenca, S.A. (LLYC.MC) Income Statement Analysis – Financial Results
Complete financial analysis of Thorne HealthTech, Inc. (THRN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Thorne HealthTech, Inc., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Civitas Social Housing PLC (CSH.L) Income Statement Analysis – Financial Results
- INNOX Advanced Materials Co.,Ltd. (272290.KQ) Income Statement Analysis – Financial Results
- Ogura Clutch Co.,Ltd. (6408.T) Income Statement Analysis – Financial Results
- Centor Energy, Inc. (CNTO) Income Statement Analysis – Financial Results
- Washington H. Soul Pattinson and Company Limited (WSOUF) Income Statement Analysis – Financial Results
Thorne HealthTech, Inc. (THRN)
About Thorne HealthTech, Inc.
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 228.73M | 185.25M | 138.45M | 102.53M |
| Cost of Revenue | 113.80M | 87.89M | 73.67M | 57.79M |
| Gross Profit | 114.93M | 97.35M | 64.79M | 44.74M |
| Gross Profit Ratio | 50.25% | 52.55% | 46.79% | 43.64% |
| Research & Development | 7.42M | 5.94M | 4.22M | 3.90M |
| General & Administrative | 75.59M | 54.91M | 0.00 | 0.00 |
| Selling & Marketing | 26.44M | 25.19M | 0.00 | 0.00 |
| SG&A | 102.03M | 80.10M | 59.55M | 54.75M |
| Other Expenses | 1.34M | -87.83K | -244.16K | -254.37K |
| Operating Expenses | 109.45M | 86.04M | 63.77M | 58.65M |
| Cost & Expenses | 223.25M | 173.93M | 137.44M | 116.44M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 26.33K | 449.91K | 1.13M | 406.42K |
| Depreciation & Amortization | 4.82M | 5.93M | 4.30M | 4.34M |
| EBITDA | 10.31M | 15.68M | 5.07M | -9.56M |
| EBITDA Ratio | 4.51% | 8.46% | 3.66% | -9.33% |
| Operating Income | 5.48M | 9.75M | 770.61K | -13.91M |
| Operating Income Ratio | 2.40% | 5.26% | 0.56% | -13.56% |
| Total Other Income/Expenses | 2.32M | 1.17M | -3.28M | -2.65M |
| Income Before Tax | 7.80M | 10.92M | -2.27M | -16.56M |
| Income Before Tax Ratio | 3.41% | 5.90% | -1.64% | -16.15% |
| Income Tax Expense | -7.31M | 411.92K | 176.76K | 33.42K |
| Net Income | 15.67M | 10.51M | -2.44M | -16.59M |
| Net Income Ratio | 6.85% | 5.67% | -1.77% | -16.18% |
| EPS | 0.30 | 0.33 | -0.05 | -0.46 |
| EPS Diluted | 0.30 | 0.33 | -0.05 | -0.46 |
| Weighted Avg Shares Out | 52.76M | 32.33M | 51.21M | 36.43M |
| Weighted Avg Shares Out (Dil) | 52.76M | 32.33M | 51.21M | 36.43M |
Thorne HealthTech taps former Vitamin Shoppe CEO Watts as leader
L Catterton Completes Acquisition of Thorne HealthTech, Inc.
L Catterton and Thorne HealthTech, Inc. Announce Expiration of Tender Offer
L Catterton and Thorne HealthTech, Inc. Announce Expiration of Tender Offer
THORNE HEALTHTECH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Thorne HealthTech, Inc. -THRN
THORNE HEALTHTECH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Thorne HealthTech, Inc. -THRN
Shareholder Alert: Ademi LLP investigates whether Thorne HealthTech, Inc. has obtained a Fair Price in its transaction with L Catterton
THRN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Thorne HealthTech, Inc. Is Fair to Shareholders
Thorne HealthTech stock posts big gain on go-private merger with L Catterton
Thorne HealthTech, Inc. Enters into Definitive Agreement to be Acquired by L Catterton for $10.20 Per Share in Cash
Source: https://incomestatements.info
Category: Stock Reports